| Model Number |
459888 |
| Medical Device Problem Code |
Failure to Capture (1081)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/22/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that the patient received inappropriate therapy while swimming in a pool.A review of the episode by qualified personnel determined that there was inhibition of pacing related to oversensing of electromagnetic interference (emi).There was a lead integrity alert (lia) triggered due to high rate non-sustained (hrns) episodes and sensing integrity counter (sic).It was further reported that a loss of capture was suspected on the right ventricular (rv) and left ventricular (lv) leads after the shock was delivered.There was undefined high rv pacing impedance, t-wave oversensing (twos), and a known rv tip electrode fracture.The leads were reprogrammed and remain in use.The cardiac resynchronization therapy defibrillator (crt-d) remains in use.No further patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Continuation of d10: 6935m72 lead implanted: (b)(6) 2015; 5086mri52 lead implanted (b)(6) 2013.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was further reported that the cardiac resynchronization therapy defibrillator (crt-d) and right ventricular (rv) lead were later explanted and replaced when the patient was downgraded to a biventricular pacemaker system, and the left ventricular (lv) lead rema ins in use.
|
| |
|
Additional Manufacturer Narrative
|
|
Corrected: h6 annex b, c and d.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|